Lipid lowering therapy in the treatment of lower limb atherosclerosis.
Leng
G C
GC
University of Edinburgh Medical School, U.K.
Price
J F
JF
Jepson
R G
RG
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001161:Arteriosclerosis / Q000401:mortality / Q000628:therapy*; D002986:Clinical Trials as Topic; D003625:Data Collection; D016206:Databases, Bibliographic; D006801:Humans; D006949:Hyperlipidemias / Q000628:therapy*; D007866:Leg / Q000098:blood supply*; D008074:Lipoproteins / Q000097:blood / Q000187:drug effects; D011341:Probucol / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic
D000924:Anticholesteremic Agents; D008074:Lipoproteins; D011341:Probucol